DUBLIN--(BUSINESS WIRE)--The "Sebia SA - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering. Summary Sebia SA (Sebia) is a medical device ...
The next generation instrument for screening hemoglobin disorders in newborns. LISSES, France, April 05, 2024--(BUSINESS WIRE)--Sebia, a global specialty diagnostic company providing innovative ...
Sebia, a market leader in protein electrophoresis and tests for the diagnosis of haemoglobin disorders, announces the debut of its Haemoglobins Atlas. This tool, which has been developed for the first ...
Sebia has announced the launch of its next generation separation method for HbA1c testing. The new test used with Sebia’s automated capillary electrophoresis product, Capillarys™ Two Flex Piercing, ...
Sebia, a global specialty diagnostic company, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for CAPILLARYS 3 DBS devices. Our solution is intended for ...
Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results